Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vega, R. B.
Right arrow Articles by Kelly, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vega, R. B.
Right arrow Articles by Kelly, D. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 50, Issue of December 12, 1997 pp. 31693-31699

A Role for Estrogen-related Receptor alpha  in the Control of Mitochondrial Fatty Acid beta -Oxidation during Brown Adipocyte Differentiation*

(Received for publication, August 18, 1997, and in revised form, September 12, 1997)

Rick B. Vega Dagger and Daniel P. Kelly Dagger §

From the Center for Cardiovascular Research, Departments of § Medicine and Dagger  Molecular Biology & Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
Note Added in Proof
REFERENCES


ABSTRACT

Little is known about the factors involved in the brown adipocyte gene regulatory program. In contrast to the white adipocyte, the brown adipocyte is characterized by abundant mitochondria and high level expression of mitochondrial fatty acid beta -oxidation enzymes. Previous studies in transgenic mice have shown that the brown adipose-enriched expression of a key beta -oxidation enzyme, medium chain acyl-coenzyme A dehydrogenase (MCAD), requires cis-acting elements located within the proximal promoter region of the MCAD gene. The levels of mRNA encoding MCAD and several other beta -oxidation cycle enzymes were coordinately induced during differentiation of brown adipocytes in culture. Expression of transgenes comprised of MCAD gene promoter fragments fused to chloramphenicol acetyltransferase reporters in differentiating brown adipocytes revealed that a known nuclear receptor response element (NRRE-1) was required for the transcriptional induction of the MCAD gene during brown adipocyte differentiation. Electrophoretic mobility shift assays and antibody recognition studies identified distinct brown adipocyte differentiation stage-specific, NRRE-1-protein complexes; the orphan nuclear receptors, chicken ovalbumin upstream promoter transcription factors I and II, were identified as major the NRRE-1 binding proteins in the pre-adipocyte, whereas the estrogen-related receptor alpha  (ERRalpha ) bound NRRE-1 in extracts prepared from differentiated brown adipocytes. DNA binding studies performed with a series of NRRE-1 mutant probes indicated that ERRalpha was capable of binding two distinct sites within NRRE-1, each of which conform to the known ERRalpha monomeric binding consensus. The expression of ERRalpha paralleled NRRE-1 binding activities and MCAD expression during brown adipocyte differentiation, cardiac development, and among a variety of adult mouse tissues. These results identify a new class of ERRalpha target genes and implicate ERRalpha and chicken ovalbumin upstream promoter transcription factor in the control of a pivotal metabolic pathway during brown adipocyte differentiation.


INTRODUCTION

In contrast to the white adipocyte, which functions mainly as a lipid storage cell, the brown adipocyte is a specialized thermogenic cell characterized by the presence of the mitochondrial uncoupling protein (UCP).1 UCP functions to disrupt the proton gradient across the inner mitochondrial membrane resulting in the "uncoupling" of oxidative phosphorylation and dissipation of energy as heat. Evidence is emerging that in addition to thermogenesis, brown adipose tissue (BAT) plays a pivotal role in mammalian whole body energy homeostasis and control of body weight (1-4). Fatty acid beta -oxidation provides the reducing equivalents for the mitochondrial uncoupling reaction. Thus, flux through the beta -oxidation cycle is one important determinant of the rate of uncoupling of oxidative phosphorylation in a given tissue. The majority of cellular fatty acid oxidation occurs in the mitochondria via a four-step cycle catalyzed by nuclear-encoded enzymes (5). The expression of mitochondrial fatty acid oxidation enzymes is very high in BAT and other tissues with high oxidative energy demands, such as heart. Accordingly, in contrast to the white adipocyte, the brown adipocyte has abundant mitochondria and a high capacity for fatty acid oxidation.

Little is known about the brown adipocyte differentiation program or about the molecular regulatory factors that distinguish BAT from white adipose tissue. Recently, several factors involved in the general adipocyte program have been elucidated. The peroxisome proliferator-activated receptor gamma  (PPARgamma ), a member of the nuclear receptor transcription factor superfamily, plays a pivotal role in adipocyte differentiation. In the presence of activators of PPARgamma , ectopic overexpression of this nuclear receptor has been shown to trigger the adipocyte program in a variety of cells, including non-adipocytes (6, 7). Members of the C/EBP family of transcription factors have also been shown to be critical components of the adipogenic differentiation program (8, 9). These factors, however, are common to the brown and white adipocyte and, thus, are unlikely to account for the biochemical and structural differences between the two cell types.

To understand the molecular regulatory mechanisms involved in the control of the mitochondrial beta -oxidation pathway in BAT and as an initial step toward the elucidation of the factors involved in the brown adipocyte differentiation program, we have begun to dissect the regulatory pathway controlling expression of genes encoding mitochondrial fatty acid oxidation enzymes in BAT. To this end, we have focused on the nuclear gene encoding, medium chain acyl-coenzyme A dehydrogenase (MCAD) (2,3-oxidoreductase, EC 1.3.99.3), a pivotal enzyme in the mitochondrial fatty acid beta -oxidation cycle. These studies revealed that a complex nuclear receptor response element (NRRE-1), located in the proximal region of the human MCAD gene promoter, is required for high level transcription of a reporter gene in BAT and heart in adult transgenic mice (10). Studies performed in vitro have shown that NRRE-1 is a pleiotropic element capable of conferring transcriptional activation via several nuclear receptors including the retinoid X receptor (RXR) and PPARalpha (11) or repression by the orphan receptors chicken ovalbumin upstream promoter transcription factors I and II (COUP-TF I and II; Ref. 12). However, the endogenous nuclear receptors that interact with NRRE-1 in the brown adipocyte in vivo have not been identified.

In this report we demonstrate that NRRE-1 is necessary for the transcriptional induction of the MCAD gene during brown adipocyte differentiation in culture and describe the identification of two endogenous nuclear receptors that bind NRRE-1. NRRE-1 is shown to interact with COUP-TF I and II in the pre-brown adipocyte, whereas the orphan receptor estrogen-related receptor alpha  or ERRalpha binds NRRE-1 in the differentiated brown adipocyte. Moreover, we show that the expression of ERRalpha during brown adipocyte differentiation and among mouse tissues parallels MCAD expression and the known tissue-specific differences in beta -oxidation rates. These results implicate members of the nuclear receptor superfamily in a pivotal brown adipocyte metabolic gene regulatory program and identify a potential role for ERRalpha in the control of mitochondrial fatty acid oxidation.


MATERIALS AND METHODS

Primary Brown Adipocyte Isolation and Culture

Brown pre-adipocytes were isolated from the interscapular brown fat pads of 3-4-week-old C57Bl/6xSJL mice as described (13). In brief, the fat pads were removed and digested with collagenase. The digested tissue was sequentially passed through 250- and 60-µm nylon filters. The filtrate was centrifuged at 800 × g to pellet the stromal vascular cell fraction. The cells were grown in Dulbecco's modified Eagle's medium/F-12 (Cellgro, Mediatech) plus 10% fetal calf serum. On day 3 of culture, one-half of the media was removed and replaced with differentiation media containing 20 nM insulin and 2 nM triiodothyronine. On day 9, all of the media was replaced with fresh differentiation media. The cells were originally plated at a density such that confluency was reached by day 6. Using this approach, greater than 75% of the cells were differentiated by day 10. The cells were judged to be differentiated based on the appearance of multilocular lipid droplets and a marked increase in mitochondrial size and number as judged by light and electron microscopy.

Northern Blot Analysis

Total RNA was isolated from brown adipocytes in culture using the RNAzol (Tel-Test, Inc.) method. Northern blot analysis was performed as described (14) using cDNA probes labeled to high specific activity via the random-primed labeling technique. Probes used included a mouse MCAD cDNA (10), a rat long chain acyl-CoA dehydrogenase cDNA (a gift from Dr. Bryan Hainline, Indiana University), a cDNA encoding human beta  subunit of 3-OH long chain acyl-CoA dehydrogenase, (a gift from Dr. Arnold Strauss, Washington University), and a PPARgamma cDNA (a gift from Dr. Jeff Gimble, Oklahoma Medical Research Foundation). An 18 S rRNA probe signal was used as a control for loading amounts.

Transgenic Mice and CAT Assays

The MCADCAT.371 and MCADCATDelta NRRE-1 transgenic mouse lines have been described (10). CAT activity assays were performed with protein extracts prepared from primary brown adipocytes isolated from pooled litters of 21-day-old MCADCAT.371 (line 10-1) and MCADCATDelta NRRE-1 mice (line 11-3) as described (10). In brief, cells were harvested at the indicated time points using a commercial lysis buffer per manufacturer's (Promega) instructions. Protein concentrations of the lysates were determined by the Lowry method. Fifty micrograms of protein was used for each assay. CAT activity assays were performed using n-butyryl-coenzyme A and [14C]chloramphenicol as substrates. Butyrylated [14C]chloramphenicol was separated from free chloramphenicol by xylene extraction. Labeled chloramphenicol was quantified by scintillation counting on a Beckman LS 6000IC scintillation counter.

Electrophoretic Mobility Shift Assays (EMSA)

Preparation of crude nuclear protein extracts from cells and tissues and EMSA were performed as described (10, 15) using the double-stranded oligonucleotide probes shown in Fig. 5B. The SF-1 probe sense strand sequence is 5'-GAGTTTTTCAAGGTCATGCTCAATTT-3'. The probes were incubated with 10 µg of total nuclear protein or 2 µl of in vitro transcribed/translated ERRalpha . In vitro transcription was performed with a human ERRalpha cDNA template generously provided by Dr. Christine Teng (National Institute of Environmental Health Sciences). Double-stranded oligonucleotide probes were 32P-labeled by Klenow "fill-in" of a 5'-GATC overhang. Recombinant human ERRalpha was produced using the TNT-coupled reticulocyte lysate system (Promega) per the manufacturer's instructions. Competition EMSA experiments were performed by addition of a molar excess of unlabeled, unrelated, size-matched double-stranded oligonucleotides or unlabeled NRRE-1 or NRRE-1 mutant oligonucleotides. Antibody supershift experiments were performed with polyclonal antibodies directed against human ERRalpha (a gift from Dr. Vincent Giguere, McGill University), COUP-TF I/II (MP33) and COUP-TF I (MP31) (gifts from Dr. M. G. Parker, Imperial Cancer Research Fund), and a mixture of monoclonal antibodies directed against RXRalpha , -beta , -gamma (a gift from Dr. Pierre Chambon, Institut National de la Santé et de la Recherche Médicale). Antibody supershift studies were carried out by incubating the protein extract with preimmune serum or specific antibodies on ice for 15 min. The complete binding reaction mix including buffer, poly(dI·dC), and labeled probe were then added to the extract and sera and incubated at room temperature for 20 min before resolving on 5% non-denaturing polyacrylamide gel.


Fig. 5. ERRalpha binds NRRE-1 at sites 1 and 3. A, using EMSA, in vitro transcribed/translated ERRalpha (ERRalpha lysate) was tested for its ability to bind NRRE-1 and compared with the results with nuclear protein extracts (NE) prepared from BAT and unprogrammed reticulocyte lysate (Unprog. Lysate). ERRalpha antibody (ERR Ab) was added to lane 4 to confirm the presence of ERRalpha in the complex. B, sense-strand sequences of the oligonucleotide probes used in the EMSA shown in C. The location and relative orientation of the three potential hexameric receptor binding half-sites within NRRE-1 are denoted by the arrows. The single base pair substitutions in mutant probes M1, M2, and M3 are underlined. C, cross-competition (lanes 1-7) with 100-fold molar excess of NRRE-1 (Sp), unrelated (NS), a known ERRalpha recognition site (SF1), or NRRE-1 mutants (M1, M2, and M3). In lanes 8-10, 32P-labeled wild-type (wt) M1, and M3 probes were incubated with BAT nuclear protein extract prepared from differentiated brown adipocytes.

[View Larger Version of this Image (30K GIF file)]


Western Blot Studies

Analysis was performed with 5 µg of total nuclear protein lysate prepared from pre- and post-brown adipocytes or mouse heart (embryonic day 20 and adult). For the tissue expression panel, 10 µg of whole cell extract was used. Tissue protein lysates were prepared by homogenization of the tissue in lysis buffer (10 mM Tris, 5 mM EGTA, 0.1 mM dithiothreitol, 2 mM phenylmethylsulfonyl fluoride, 0.125 mg of leupeptin, and 0.5% SDS) followed by removal of cellular debris by centrifugation at 15,000 × g. A modification of the protein immunoblot analysis by Burnette (16) was performed using the enhanced chemiluminescence detection system (Amersham Corp.). The anti-ERRalpha and anti-COUP-TF antibodies described above were used. The anti-MCAD antibody has been described (17).


RESULTS

The Expression of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes Is Induced during Brown Adipocyte Differentiation---To examine the expression of nuclear genes involved in mitochondrial fatty acid beta -oxidation during brown adipocyte differentiation, levels of mRNAs encoding enzymes catalyzing the first (medium chain acyl-CoA dehydrogenase (MCAD) and long chain acyl-CoA dehydrogenase) and third (3-hydroxy long chain acyl-CoA dehydrogenase) steps of the mitochondrial beta -oxidation cycle were delineated by RNA blot analysis. Expression of long chain fatty-acyl-CoA synthetase, which catalyzes the thioesterification of free fatty acids following cellular import was also analyzed. For these experiments, primary pre-brown adipocytes were cultured following isolation from the interscapular brown fat pad of 3-4-week-old C57Bl/6xSJL mice. The pre-adipocytes were grown to confluency and induced to differentiate using an established protocol described previously (see Ref. 18 and "Materials and Methods"). Total RNA was isolated from subconfluent pre-adipocytes and differentiated brown adipocytes. The differentiated cells exhibited the morphological characteristics typical of brown adipocytes including the appearance of intracellular, multilocular lipid droplets and abundant, large mitochondria. The levels of mRNA encoding long chain fatty-acyl-CoA synthetase and the beta -oxidation cycle enzymes was markedly higher in the differentiated brown adipocytes compared with that of the pre-adipocytes (Fig. 1). Expression of PPARgamma , a known marker for adipocyte differentiation (19), was also induced confirming that the adipocyte program was activated in this cell culture system.


Fig. 1. Coordinate induction of the expression of genes encoding mitochondrial beta -oxidation enzymes during brown adipocyte differentiation. Autoradiogram of a representative Northern blot analysis performed with total RNA isolated from murine primary brown adipocytes grown in culture. RNA was isolated from cells harvested at the pre-adipocyte stage (Pre) or from mature brown adipocytes (Post). Using the differentiation protocol described under "Materials and Methods," greater than 75% of the cells were differentiated at the Post stage. 5 µg of total RNA was loaded per lane. The blot was hybridized with the radiolabeled cDNA probes denoted on the right. The 18 S ribosomal RNA signal is shown as a control for loading. FACS, long chain fatty-acyl-CoA synthetase.

[View Larger Version of this Image (42K GIF file)]


Transcriptional Activation of the MCAD Gene during Brown Adipocyte Differentiation Requires a Nuclear Receptor Response Element

We have shown previously that a 560-base pair human MCAD promoter fragment fused to a chloramphenicol acetyltransferase reporter (MCADCAT.371) is expressed at high levels in BAT in parallel with the endogenous MCAD gene in adult transgenic mice (10). In contrast, expression of a transgene (MCADCATDelta NRRE-1) that differs only in a 54-base pair deletion of a region containing a known nuclear receptor response element (NRRE-1) is not BAT-enriched (10). To determine whether the induction of MCAD gene expression during brown adipocyte differentiation occurs at the level of transcription and to define the role of NRRE-1 in this regulation, transgene expression was characterized during differentiation of pre-brown adipocytes isolated from MCADCAT.371 and MCADCATDelta NRRE-1 mice. Transgene expression was determined by measurement of CAT activity in lysates prepared from the cultured cells at different time points following a switch to differentiation media (see "Materials and Methods"). Day 0 represents the point at which the pre-adipocytes reached confluency. By day 4 greater than 75% of the cells exhibited the mature brown adipocyte phenotype as judged by the morphological characteristics described under "Materials and Methods" and gene markers shown in Fig. 1. CAT activity in the MCADCAT.371 cells increased markedly (12-13 fold) upon differentiation (Fig. 2). This dramatic induction of CAT activity corresponded with the appearance of immunodetectable endogenous MCAD protein (Fig. 2). In contrast, expression of the MCADCATDelta NRRE-1 transgene, which lacks NRRE-1, was unchanged during differentiation of the cultured brown adipocytes (Fig. 2). These results indicate that the induction of MCAD gene expression during brown adipocyte differentiation occurs at the level of transcription and requires the nuclear receptor response element, NRRE-1.


Fig. 2. Induction of MCADCAT.371 transgene expression during brown adipocyte differentiation. Primary brown adipocytes were isolated from mice transgenic for MCADCAT.371 or MCADCATDelta NRRE-1, as described under "Materials and Methods." As shown in the schematic at the bottom, NRRE-1 was deleted in the MCADCATDelta NRRE-1 construct (the numbers are relative to the transcription start site = +1). The pre-brown adipocytes reached confluency on day 0. By day 4, greater than 75% of the cells were differentiated using the criteria described under "Materials and Methods" and by the gene markers shown in Fig. 1. CAT activity, normalized to levels at day 0, are shown for MCADCAT.371 and MCADCATDelta NRRE-1. The values represent mean (± S.E.) CAT activity from pooled cells from at least three independent experiments. The inset contains a representative Western blot analysis (5 µg of total protein/lane) performed with an anti-MCAD antibody using the protein extract samples used to determine CAT activities.

[View Larger Version of this Image (17K GIF file)]


Identification of Brown Adipocyte Differentiation Stage-specific NRRE-1 Binding Activities

Electrophoretic mobility shift assays (EMSA) were performed to begin to characterize the transcription factors involved in the induction of MCAD gene transcription during brown adipocyte differentiation. For these experiments, an NRRE-1 probe was incubated with nuclear protein extracts isolated from pre- and post-brown adipocytes. As shown in Fig. 3A, distinct NRRE-1 binding patterns were obtained with the two types of nuclear extracts. Two complexes (pI and pII) of similar but distinct mobilities formed with nuclear protein extracts prepared from pre-brown adipocytes. When the EMSA were performed with extracts prepared from the differentiated brown adipocytes, neither complex pI or pII was observed; rather two new NRRE-1-protein complexes formed (dI and dII; Fig. 3A). dI was a faint, low mobility complex, and complex dII was a prominent complex migrating slightly faster than pI and pII. We have shown previously that NRRE-1-protein complexes of identical mobilities to that of dI and dII also form with nuclear protein extracts prepared from adult mouse heart and the brown adipocyte cell line HIB-1B (Ref. 10 and data not shown). Competition experiments performed with a molar excess of specific (NRRE-1) or an unrelated, size-matched, double-stranded oligonucleotide confirmed that all four complexes represented specific NRRE-1/protein interactions (Fig. 3B). These data identify brown adipocyte differentiation stage-specific NRRE-1 binding activities and suggest that distinct transcription factors interact with NRRE-1 during different stages of brown adipocyte differentiation.


Fig. 3. NRRE-1 interacts with pre- and post-brown adipocyte nuclear proteins in a cell differentiation stage-specific pattern. A, the results of EMSA performed with an NRRE-1 probe and nuclear proteins isolated from pre- and post-brown adipocytes. Distinct NRRE-1-protein complexes pI and pII in the pre-adipocytes and complexes dI and dII in the post-differentiated adipocytes are labeled. B, results of EMSA competition studies with the NRRE-1 probe and nuclear protein extracts prepared from pre- and post-differentiated brown adipocytes. A 100-fold molar excess of an unlabeled, unrelated size-matched double-stranded oligonucleotide (NS) or 10-, 50-, or 100-fold molar excess of an unlabeled NRRE-1 probe (ramp) were added to the incubation as denoted at the top.

[View Larger Version of this Image (36K GIF file)]


The Orphan Nuclear Receptors, COUP-TF and ERRalpha , Bind NRRE-1 in a Brown Adipocyte Differentiation Stage-specific Manner

Antibody recognition studies were performed to identify the proteins bound to NRRE-1 in the complexes shown Fig. 3. A panel of antibodies raised against various members of the nuclear receptor superfamily were used in these studies. The initial studies focused on the protein-DNA complexes (pI and pII) formed with the pre-adipocyte nuclear protein extracts. Antibodies to RXRalpha , PPARalpha , PPARgamma , thyroid receptor alpha , and the orphan receptor, ERRalpha , did not recognize proteins in complex pI or pII (Fig. 4 and data not shown). However, an anti-COUP-TF antibody that recognizes both COUP-TF I and COUP-TF II isoforms (MP33; Ref. 20) abolished the formation of complexes pI and pII (Fig. 4, lane 4). Addition of a COUP-TF II-specific antibody (MP31) prevented the formation of complex pI but not complex pII. Accordingly, complex pI and pII contain COUP-TF I and II or closely related proteins. These data are consistent with the results of our previous characterization of NRRE-1 demonstrating that COUP-TF I, overproduced in bacteria, binds NRRE-1 (12). We have also shown that overexpression of COUP-TF I in mammalian cell lines in culture represses transcription of an MCAD promoter-reporter construct via NRRE-1 (12).


Fig. 4. Identification of COUP-TF and ERRalpha in NRRE-1-brown adipocyte nuclear protein complexes by antibody recognition experiments. The autoradiographs depicted above represent EMSA antibody recognition studies performed with an NRRE-1 probe and anti-ERRalpha or anti-COUP-TF (MP31 and MP33) antibodies (Ab). MP33 recognizes COUP-TF I and II, and MP31 is specific for COUP-TF II. Preimmune (PI) serum was used to serve as a negative control.

[View Larger Version of this Image (74K GIF file)]


The antibody EMSA studies were repeated with nuclear protein extracts prepared from differentiated brown adipocytes. Initial studies focused on the prominent NRRE-1-protein complex dII shown in Fig. 3. Previous EMSA and cell cotransfection studies have demonstrated that RXRalpha /PPARalpha heterodimers bind NRRE-1 to activate transcription from heterologous and homologous promoters (11). These results together with the known role of PPARgamma in the adipocyte differentiation program suggested that complex dII may contain PPAR/RXR heterodimers bound to NRRE-1. Surprisingly, however, complex dII was not recognized by anti-RXRalpha , anti-PPARalpha , or anti-PPARgamma antibodies (data not shown). The anti-COUP antibodies, MP31 and MP33, also failed to influence the formation or mobility of complex dII (Fig. 4, lane 8). However, an antibody to the orphan nuclear receptor ERRalpha abolished the formation of complex dII (Fig. 4, lane 9). Taken together with the results shown above, these data strongly suggest that the known transcriptional repressors COUP-TF I and II bind NRRE-1 to silence MCAD gene expression in the pre-brown adipocyte but that during brown adipocyte differentiation the orphan receptor ERRalpha becomes the predominant NRRE-1 binding protein.

Regarding the faint complex dI, none of the antibodies used above, including the anti-COUP-TF antibodies, affected its formation or mobility (data not shown). However, we have shown previously that NRRE-1-protein complexes with mobilities identical to that of dI formed with nuclear extracts prepared from adult mouse heart or HIB-1B cells were recognized by a separate anti-COUP-TF antiserum raised to COUP-TF I purified from HeLa cells (21). This antibody, which also prevented the formation of complex dI (data not shown), has been shown to recognize at least two other higher molecular weight proteins in addition to COUP-TF I (21). Thus, we conclude that complex dI does not contain COUP-TF I or COUP-TF II but may contain a structurally related protein.

The MCAD ERRalpha Recognition Site Requires Two Receptor Binding Half-site Sequences Arranged as an Imperfect Everted Repeat

To confirm that ERRalpha binds NRRE-1, EMSA were performed with recombinant ERRalpha protein produced in an in vitro coupled reticulocyte lysate transcription/translation reaction. NRRE-1 formed a single prominent complex with the recombinant ERRalpha but not with unprogrammed lysate (Fig. 5A, lanes 2 and 3). The mobility of the NRRE-1-recombinant ERRalpha complex was identical to that of the endogenous complex (complex dII) formed with post-BAT nuclear protein extract (Fig. 5A, lanes 1 and 3). Addition of anti-ERRalpha antibody prevented the formation of the recombinant ERRalpha ·NRRE-1 complex demonstrating the presence of ERRalpha (Fig. 5A, lane 4). These results confirm that NRRE-1 contains an ERRalpha recognition site. Moreover, the similar mobilities of complex dII and the NRRE-1-recombinant ERRalpha complex suggests that complex dII contains only ERRalpha .

NRRE-1 is a novel, pleiotropic element composed of three potential nuclear receptor binding half-site sequences (shown in Fig. 5B). We have shown previously (12) that the unique arrangement of the hexameric receptor binding half-sites within NRRE-1 dictates three potential receptor dimer binding elements; an everted imperfect repeat separated by 13 bases (ER-13, sites 1 and 3), an ER-8 (sites 1 and 2), and an imperfect direct repeat (DR-O, sites 2 and 3). To define the ERRalpha binding site requirements within NRRE-1, EMSA competition studies were performed. Recombinant ERRalpha protein was used for these studies. As expected, a molar excess of unlabeled NRRE-1 prevented formation of the NRRE-1·ERRalpha complex, whereas an identical molar excess of a nonspecific, size-matched probe had no effect on its formation (Fig. 5C, lanes 1-3). Previous studies by others (22) have demonstrated that ERRalpha binds with high affinity to the extended half-site sequence, 5'-TCAAGGTCA-3', present in the steroidogenic factor 1 (SF-1) consensus binding site. A probe containing the SF-1 site was also efficient at preventing the ERRalpha ·NRRE-1 complex formation (Fig. 5B, lane 4). To define the NRRE-1 binding sites necessary for ERRalpha binding, competition studies were performed with mutated NRRE-1 oligonucleotide fragments containing G to C substitutions at the invariant second position within each of the three potential receptor binding half-sites (sequences are shown in Fig. 5B). Although the NRRE-1 site 2 mutant (M2) was capable of competing with NRRE-1, the site 1 (M1) and site 3 (M3) mutants did not prevent complex formation (Fig. 5C, lanes 5-7). These results suggest that ERRalpha interacts with sites 1 and 3 within NRRE-1. Finally, to determine whether NRRE-1 sites 1 and 3 were required for the interaction of NRRE-1 with endogenous ERRalpha , nuclear protein extracts prepared from differentiated brown adipocytes were incubated with radiolabeled NRRE-1, M1, or M3 probes. The ERRalpha ·NRRE-1 complex did not form with the M1 probe and was markedly diminished with the M3 probe (Fig. 5A, lanes 12-14). Taken together, these data indicate that ERRalpha binds NRRE-1 sites 1 and 3, possibly as a dimer. Of note, we have shown previously that recombinant COUP-TF I homodimers bind NRRE-1 at sites 1 and 3 (12) and that this complex co-migrates with complex pII (data not shown).

Expression of ERRalpha Parallels Expression of the MCAD Gene during BAT Differentiation and among Murine Tissues

The results shown above implicate ERRalpha in the control of nuclear genes encoding MCAD and other mitochondrial fatty acid oxidation enzymes during brown adipocyte differentiation. To determine whether the nuclear expression of ERRalpha parallels its NRRE-1 binding activity and MCAD expression during differentiation of the brown adipocyte, Western blot studies were performed with nuclear protein extracts prepared from pre- and post-adipocytes. Steady-state nuclear levels of ERRalpha were markedly induced during the transition from pre- to post-brown adipocyte (Fig. 6A). The induction of ERRalpha expression during brown adipocyte differentiation paralleled MCAD protein levels (Fig. 6A), the transcriptional activity of the MCADCAT.371 transgene (Fig. 2), and NRRE-1 binding activities (Fig. 3). In contrast, COUP-TF was expressed in a reciprocal pattern during adipocyte differentiation as predicted by NRRE-1 binding activity (Fig. 3) and the known role of COUP-TF as a transcriptional repressor of the MCAD gene (12).


Fig. 6. Expression patterns of ERRalpha and COUP-TF compared with MCAD. A, Western blot analysis using anti-ERRalpha and anti-COUP-TF antisera with nuclear protein extracts prepared from pre- and post-differentiated brown adipocytes (BAT) and embryonic day 20 (e20) and adult mouse heart. Whole cell protein extracts were used to determine steady-state MCAD levels. Each lane contains 5 µg of total protein. B, Western blot analysis of ERRalpha compared with MCAD in whole cell protein extracts prepared from a variety of adult murine tissues. Each lane contains 10 µg of total cellular protein.

[View Larger Version of this Image (49K GIF file)]


ERRalpha and COUP-TF expression was also examined in the perinatal developing heart. The expression of mitochondrial fatty acid beta -oxidation enzymes is known to be markedly induced in heart following birth as the chief myocardial energy substrate switches from glucose to fatty acids. Levels of ERRalpha were induced from the fetal (embryonic day 20) to adult mouse heart in parallel with MCAD protein levels, whereas COUP-TF expression followed a reciprocal pattern (Fig. 6A). These results implicate ERRalpha and COUP-TF in the differential transcriptional control of nuclear genes involved in mitochondrial beta -oxidation during brown adipocyte differentiation and perinatal cardiac development.

The expression of ERRalpha was also delineated in a variety of adult mouse tissues with distinct capacities for mitochondrial fatty acid oxidation. The tissue expression pattern of ERRalpha was compared with that of MCAD. ERRalpha expression was greatest in tissues with high capacity for fatty acid oxidation and abundant expression of MCAD, such as BAT and heart (Fig. 6B). In contrast, ERRalpha expression was low in white adipose tissue, brain, and lung, tissues with low beta -oxidation rates. These data suggest that in addition to the control of beta -oxidation enzyme expression during adipocyte differentiation and perinatal cardiac development, ERRalpha plays a role in the expression of mitochondrial beta -oxidation enzymes among adult mammalian tissues.


DISCUSSION

The molecular regulatory mechanisms involved in the commitment to separate brown and white adipocyte differentiation programs are presently unknown. One of the major biochemical differences between white and brown adipose tissue is the level of mitochondrial fatty acid beta -oxidation. Although the white adipocyte is a storage depot for fatty acids, the brown adipocyte actively metabolizes fatty acids to produce reducing equivalents for the mitochondrial uncoupling reaction. Differentiation of the brown adipocyte leads to a marked increase in the expression of nuclear genes encoding mitochondrial fatty acid beta -oxidation enzymes coincident with a dramatic increase in the size and number of mitochondria. We sought to define the transcriptional regulatory pathway responsible for high level expression of fatty acid oxidation enzyme genes in BAT as an initial step in the elucidation of the brown adipocyte gene regulatory program. In this report, we provide evidence for the role of two orphan nuclear receptors, COUP-TF and ERRalpha , in the transcriptional control of a pivotal beta -oxidation enzyme gene during brown adipocyte differentiation.

The mitochondrial UCP, a distinctive and specific marker for the brown adipocyte, has been a major focus of investigation of BAT gene expression. Characterization of the UCP promoter has implicated several transcription factors that appear to interact in a complex manner to direct high level UCP gene expression. Among these factors are CREBP (23), RXR/TR (24), Ets1 (24), and RXR/PPARgamma (25). To our knowledge, none of these transcription factors exhibit BAT-enriched expression. Recently, we have identified a region of human MCAD gene promoter that is necessary for high level BAT expression in transgenic mice (10). The nuclear receptor response element, NRRE-1, is located within this MCAD gene promoter region. Previous studies performed in cell culture have shown that NRRE-1 is a pleiotropic nuclear receptor responsive element capable of conferring transcriptional activation by RXR/PPARalpha heterodimers or repression by COUP-TF homodimers (11, 12). Surprisingly, we did not detect RXR or PPAR in the NRRE-1-protein complexes formed with crude nuclear protein extracts prepared from pre- or post-differentiated brown adipocytes. Rather, a switch in NRRE-1 binding from COUP-TF to ERRalpha was identified during the transition from pre- to post-differentiated brown adipocyte. In contrast to other factors shown previously to interact with the MCAD and UCP promoters, ERRalpha is expressed in a BAT-enriched pattern. Nuclear levels of ERRalpha increase markedly during brown adipocyte differentiation. Moreover, ERRalpha expression is significantly higher in BAT compared with white adipose tissue. Accordingly, we propose that ERRalpha is a candidate regulator of the brown adipocyte mitochondrial beta -oxidation pathway.

Our observation that COUP-TF interacts with NRRE-1 in nuclear extracts prepared from the pre-brown adipocyte is consistent with its known role as a transcriptional repressor. We have shown previously that COUP-TF is a potent repressor of MCAD gene transcription and is capable of silencing retinoid-mediated transcriptional activation via NRRE-1 (12, 26). In this report we demonstrate that COUP-TF expression is highest in the pre-adipocyte, falling during differentiation. Taken together, these data strongly suggest that COUP-TF silences the expression of the MCAD gene in the pre-adipocyte.

ERRalpha was originally identified in a screen of a testis cDNA library with the estrogen receptor DNA binding domain (27). To date, few true targets for ERRalpha have been identified. ERRalpha response elements have been identified within the SV40 late promoter (28) and the human lactoferrin promoter (29). More recently, ERRalpha has been shown to activate transcription from the bone-specific osteopontin promoter in cell culture studies (30). The expression pattern of ERRalpha is consistent with a role for the receptor in bone development (30). Our ERRalpha expression studies are consistent with the NRRE-1 binding data and strongly suggest that genes involved in mitochondrial fatty acid oxidation are targets for ERRalpha . ERRalpha expression is induced during brown adipocyte differentiation and following birth in heart, in parallel with fatty acid oxidation rates and expression of beta -oxidation enzymes (10, 14, 31). Furthermore, the expression of ERRalpha among adult murine tissues parallels MCAD expression with abundant levels in tissues with high fatty acid utilization rates (BAT and heart) and low expression in less oxidative tissues such as white adipose and brain. The actual role of ERRalpha in the transcriptional control of MCAD and other beta -oxidation enzymes in vivo remains unknown. We have shown previously in cell culture studies that MCAD gene transcription is activated by PPARalpha in the presence of fatty acids or inhibitors of carnitine palmitoyltransferase I, known ligands for this nuclear receptor (11, 32, 33). Our results do not exclude the possibility that PPAR is a regulator of MCAD gene expression under certain circumstances in vivo. It is also tempting to speculate that a metabolite ligand exists for ERRalpha . The precise function of PPARalpha and ERRalpha in the expression of genes encoding MCAD and other mitochondrial beta -oxidation enzymes in vivo will require further investigation.

All ERRalpha recognition sites identified to date are extended half-site sequences similar to the SF-1 response element, 5'-TCAAGGTCA-3', to which ERRalpha binds as a monomer (22). Our results demonstrate that NRRE-1 binding sites 1 and 3 (Fig. 5B) are required for the NRRE-1/ERRalpha interaction. Indeed, the extended sequences of sites 1 (5'-GAAAGGTCA-3') and 3 (5'-TAAAGGTGA-3') are similar to the known ERRalpha binding consensus. In contrast, NRRE-1 site 2 (5'-TCCGGGTAA-3'), which is not required for ERRalpha binding, does not conform to the consensus. Our mutational EMSA studies indicate that both sites 1 and 3 are necessary for the NRRE-1/ERRalpha interaction. These results suggest that in contrast to previously defined ERRalpha targets, ERRalpha may bind NRRE-1 as a homodimer to the everted imperfect repeat comprised of sites 1 and 3. However, our data do not exclude the possibility that independent ERRalpha monomers bind NRRE-1 sites 1 and 3 in a cooperative manner.

In summary, we have demonstrated that the transcriptional induction of a nuclear gene encoding a key mitochondrial fatty acid beta -oxidation cycle enzyme during brown adipocyte differentiation requires the pleiotropic nuclear receptor response element, NRRE-1. The orphan nuclear receptors, COUP-TF and ERRalpha , were shown to bind NRRE-1 in a brown adipocyte differentiation stage-specific manner. These results implicate ERRalpha in the brown adipocyte gene regulatory program and identify genes involved in mitochondrial fatty acid oxidation as potential ERRalpha targets.


FOOTNOTES

*   This work was supported by National Institutes of Health Grant RO1-DK45416.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
   To whom correspondence should be addressed: Center for Cardiovascular Research, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8086, St. Louis, MO 63110. Tel.: 314-362-8908; Fax: 314-362-0186; E-mail: dkelly{at}imgate.wustl.edu.
1   The abbreviations used are: UCP, uncoupling protein; MCAD, medium chain acyl-coenzyme A dehydrogenase; EMSA, electrophoretic mobility shift assays; NRRE, nuclear receptor response element; ERRalpha , estrogen-related receptor alpha ; BAT, brown adipose tissue; PPARgamma , peroxisome proliferator-activated receptor gamma ; RXR, retinoid X receptor; COUP-TF, chicken ovalbumin upstream promoter transcription factor; CAT, chloramphenicol acetyltransferase.

ACKNOWLEDGEMENTS

We thank Dr. Daniel Ricquier for helpful advice concerning the primary brown adipocyte culture system, Dr. Jeffrey Saffitz for assistance in electron microscopic characterization of the adipocytes, and Kelly Hall for expert secretarial assistance.


Note Added in Proof

During review of this manuscript, Sladek et al. (34) described the regulation of MCAD gene expression by ERRalpha .


REFERENCES

  1. Lowell, B. B., S-, Susulic, V., Hamann, A., Lawitts, J. A., Himms-Hagen, J., Boyer, B. B., Kozak, L. P., and Flier, J. S. (1993) Nature 366, 740-742 [CrossRef][Medline] [Order article via Infotrieve]
  2. Fluery, C., Neverova, M., Collins, S., Raimbault, S., Champigny, O., Levi-Meyrueis, C., Bouillaud, F., Seldin, M. F., Surwit, R. S., Ricquier, D., and Warden, C. H. (1997) Nat. Genet. 15, 269-272 [CrossRef][Medline] [Order article via Infotrieve]
  3. Vidalpuig, A., Solanes, G., Grujic, D., Flier, J. S., and Lowell, B. B. (1997) Biochem. Biophys. Res. Commun. 235, 79-82 [CrossRef][Medline] [Order article via Infotrieve]
  4. Boss, O., Samec, S., Paolonigiacobino, A., Rossier, C., Dulloo, A., Seydoux, J., Muzzin, P., and Giacobino, J. P. (1997) FEBS Lett. 408, 39-42 [CrossRef][Medline] [Order article via Infotrieve]
  5. Beinert, H. (1963) in The Enzymes (Boyer, P. D., Lardy, H. J., and Myrbock, K., eds), pp. 447-476, Academic Press, Inc., New York
  6. Tontonoz, P., Hu, E., and Spiegelman, B. M. (1995) Cell 79, 1147-1156
  7. Hu, E., Tonotonoz, P., and Spiegelman, B. M. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9856-9860 [Abstract/Free Full Text]
  8. Wang, N., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., and Darlington, G. J. (1995) Science 269, 1108-1112 [Abstract/Free Full Text]
  9. Wu, Z., Xie, Y., Bucher, N. L. R., and Farmer, S. R. (1995) Genes Dev. 9, 2350-2363 [Abstract/Free Full Text]
  10. Disch, D. L., Rader, T. A., Cresci, S., Leone, T. C., Barger, P. H., Vega, R., Wood, P. A., and Kelly, D. P. (1996) Mol. Cell. Biol. 16, 4043-4051 [Abstract]
  11. Gulick, T., Cresci, S., Caira, T., Moore, D. D., and Kelly, D. P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11012-11016 [Abstract/Free Full Text]
  12. Carter, M. E., Gulick, T., Moore, D. D., and Kelly, D. P. (1994) Mol. Cell. Biol. 14, 4360-4372 [Abstract/Free Full Text]
  13. Nechad, M., Kuusela, P., Carneheim, C., Bjorntrop, P., Nedergaard, J., and Cannon, B. (1983) Exp. Cell Res. 149, 105-118 [CrossRef][Medline] [Order article via Infotrieve]
  14. Kelly, D. P., Gordon, J. I., Alpers, R., and Strauss, A. W. (1989) J. Biol. Chem. 264, 18921-18925 [Abstract/Free Full Text]
  15. Revzin, A. (1989) BioTechniques 7, 346-355 [Medline] [Order article via Infotrieve]
  16. Burnette, W. N. (1981) Anal. Biochem. 112, 195-203 [CrossRef][Medline] [Order article via Infotrieve]
  17. Kelly, D. P., Kim, J. J., Billadello, J. J., Hainline, B. E., Chu, T. W., and Strauss, A. W. (1989) Proc. Natl. Acad. Sci. U. S. A. 84, 4068-4072
  18. Cassard-Doulcier, A.-M., Gelly, C., Fox, N., Schrementi, J., Raimbault, S., Klaus, S., Forest, C., Bouillaud, F., and Ricquier, D. (1993) Mol. Endocrinol. 7, 497-506 [Abstract/Free Full Text]
  19. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., and Spiegelman, B. M. (1994) Genes Dev. 8, 1224-1234 [Abstract/Free Full Text]
  20. Butler, A. J., and Parker, M. G. (1995) Nucleic Acids Res. 23, 4143-4150 [Abstract/Free Full Text]
  21. Wang, L., Tsai, S. Y., Cook, R. G., Beattie, W. G., Tsai, M., and O'Malley, B. W. (1989) Nature 340, 163-166 [CrossRef][Medline] [Order article via Infotrieve]
  22. Johnston, S. D., Liu, X., Zuo, F., Eisenbraun, T. L., Wiley, S. R., Kraus, R. J., and Mertz, J. E. (1997) Mol. Endocrinol. 11, 342-352 [Abstract/Free Full Text]
  23. Kozak, U. C., Kopecky, J., Teisinger, J., Enerback, S., Boyer, B., and Kozak, L. P. (1994) Mol. Cell. Biol. 14, 59-67 [Abstract/Free Full Text]
  24. Cassard-Doulcier, A. M., Larose, M., Matamala, J. C., Champigny, O., Bouillaud, F., and Ricquier, D. (1994) J. Biol. Chem. 269, 24335-24342 [Abstract/Free Full Text]
  25. Sears, I. B., MacGinnitie, M. A., Kovacs, L. G., and Graves, R. A. (1996) Mol. Cell. Biol. 16, 3410-3419 [Abstract]
  26. Sack, M. N., Disch, D., Rockman, H., and Kelly, D. P. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 6438-6443 [Abstract/Free Full Text]
  27. Giguere, V., Yang, N., Segui, P., and Evans, R. M. (1988) Nature 331, 91-94 [CrossRef][Medline] [Order article via Infotrieve]
  28. Zuo, F., and Mertz, J. E. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8586-8590 [Abstract/Free Full Text]
  29. Yang, N., Shigeta, H., Shi, H., and Teng, C. T. (1996) J. Biol. Chem. 271, 5795-5804 [Abstract/Free Full Text]
  30. Bonnelye, E., Vanacker, J. M., Dittmar, T., Begue, A., Desbiens, X., Denhardt, D. T., Augin, J. E., Laudet, V., and Fournier, B. (1997) Mol. Endocrinol. 11, 905-916 [Abstract/Free Full Text]
  31. Bremer, J., and Osmundsen, H. (1984) in Fatty Acid Oxidation and Its Regulation (Numa, S., ed), pp. 13-154, Elsevier Science Publishers, B. V., Amsterdam
  32. Forman, B. M., Chen, J., and Evans, R. M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 4312-4317 [Abstract/Free Full Text]
  33. Krey, G., Braissant, O., O'Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., and Wahli, W. (1997) Mol. Endocrinol. 11, 779-791 [Abstract/Free Full Text]
  34. Sladek, R., Bader, J.-A., and Giguere, V. (1997) Mol. Cell. Biol. 17, 5400-5409 [Abstract]

Volume 272, Number 50, Issue of December 12, 1997 pp. 31693-31699
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
M. J. Chisamore, H. A. Wilkinson, O. Flores, and J. D. Chen
Estrogen-related receptor-{alpha} antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts
Mol. Cancer Ther., March 1, 2009; 8(3): 672 - 681.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. Giguere
Transcriptional Control of Energy Homeostasis by the Estrogen-Related Receptors
Endocr. Rev., October 1, 2008; 29(6): 677 - 696.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Hummasti and P. Tontonoz
Adopting New Orphans into the Family of Metabolic Regulators
Mol. Endocrinol., August 1, 2008; 22(8): 1743 - 1753.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. M. Tremblay, B. J. Wilson, X.-J. Yang, and V. Giguere
Phosphorylation-Dependent Sumoylation Regulates Estrogen-Related Receptor-{alpha} and -{gamma} Transcriptional Activity through a Synergy Control Motif
Mol. Endocrinol., March 1, 2008; 22(3): 570 - 584.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
Mst. H. Akter, T. Chano, H. Okabe, T. Yamaguchi, F. Hirose, and T. Osumi
Target Specificities of Estrogen Receptor-Related Receptors: Analysis of Binding Sequences and Identification of Rb1-Inducible Coiled-Coil 1 (Rb1cc1) as a Target Gene
J. Biochem., March 1, 2008; 143(3): 395 - 406.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Sonoda, J. Laganiere, I. R. Mehl, G. D. Barish, L.-W. Chong, X. Li, I. E. Scheffler, D. C. Mock, A. R. Bataille, F. Robert, et al.
Nuclear receptor ERR{alpha} and coactivator PGC-1beta are effectors of IFN-{gamma}-induced host defense
Genes & Dev., August 1, 2007; 21(15): 1909 - 1920.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. L. Spector, Y. Yarden, B. Smith, L. Lyass, P. Trusk, K. Pry, J. E. Hill, W. Xia, R. Seger, and S. S. Bacus
Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells
PNAS, June 19, 2007; 104(25): 10607 - 10612.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Bonnelye, R. A. Zirngibl, P. Jurdic, and J. E. Aubin
The Orphan Nuclear Estrogen Receptor-Related Receptor-{alpha} Regulates Cartilage Formation in Vitro: Implication of Sox9
Endocrinology, March 1, 2007; 148(3): 1195 - 1205.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. A. Villena, M. B. Hock, W. Y. Chang, J. E. Barcas, V. Giguere, and A. Kralli
Orphan nuclear receptor estrogen-related receptor {alpha} is essential for adaptive thermogenesis
PNAS, January 23, 2007; 104(4): 1418 - 1423.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Nichol, M. Christian, J. H. Steel, R. White, and M. G. Parker
RIP140 Expression Is Stimulated by Estrogen-related Receptor {alpha} during Adipogenesis
J. Biol. Chem., October 27, 2006; 281(43): 32140 - 32147.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
R. Rodriguez-Calvo, M. Jove, T. Coll, A. Camins, R. M. Sanchez, M. Alegret, M. Merlos, M. Pallas, J. C. Laguna, and M. Vazquez-Carrera
PGC-1{beta} Down-Regulation Is Associated With Reduced ERR{alpha} Activity and MCAD Expression in Skeletal Muscle of Senescence-Accelerated Mice.
J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2006; 61(8): 773 - 780.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. Zhang, K. Chen, J. C. Shih, and C. T. Teng
Estrogen-Related Receptors-Stimulated Monoamine Oxidase B Promoter Activity Is Down-Regulated by Estrogen Receptors
Mol. Endocrinol., July 1, 2006; 20(7): 1547 - 1561.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. B. Barry, J. Laganiere, and V. Giguere
A Single Nucleotide in an Estrogen-Related Receptor {alpha} Site Can Dictate Mode of Binding and Peroxisome Proliferator-Activated Receptor {gamma} Coactivator 1{alpha} Activation of Target Promoters
Mol. Endocrinol., February 1, 2006; 20(2): 302 - 310.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Herzog, J. Cardenas, R. K. Hall, J. A. Villena, P. J. Budge, V. Giguere, D. K. Granner, and A. Kralli
Estrogen-related Receptor {alpha} Is a Repressor of Phosphoenolpyruvate Carboxykinase Gene Transcription
J. Biol. Chem., January 6, 2006; 281(1): 99 - 106.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. S. Kim, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld
Suppression of estrogen-related receptor {alpha} and medium-chain acyl-coenzyme A dehydrogenase in the acute-phase response
J. Lipid Res., October 1, 2005; 46(10): 2282 - 2288.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
E E Connor, D L Wood, T S Sonstegard, A F da Mota, G L Bennett, J L Williams, and A V Capuco
Chromosomal mapping and quantitative analysis of estrogen-related receptor alpha-1, estrogen receptors alpha and beta and progesterone receptor in the bovine mammary gland
J. Endocrinol., June 1, 2005; 185(3): 593 - 603.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. S. J. de Souza, A. M. Santangelo, V. Bumaschny, M. E. Avale, J. L. Smart, M. J. Low, and M. Rubinstein
Identification of Neuronal Enhancers of the Proopiomelanocortin Gene by Transgenic Mouse Analysis and Phylogenetic Footprinting
Mol. Cell. Biol., April 15, 2005; 25(8): 3076 - 3086.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
D Liu, Z Zhang, and C T Teng
Estrogen-related receptor-{gamma} and peroxisome proliferator-activated receptor-{gamma} coactivator-1{alpha} regulate estrogen-related receptor-{alpha} gene expression via a conserved multi-hormone response element
J. Mol. Endocrinol., April 1, 2005; 34(2): 473 - 487.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. P. Cheung, S. Yu, K. B. Wong, L. W. Chan, F. M. M. Lai, X. Wang, M. Suetsugi, S. Chen, and F. L. Chan
Expression and Functional Study of Estrogen Receptor-Related Receptors in Human Prostatic Cells and Tissues
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1830 - 1844.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Carrier, G. Deblois, C. Champigny, E. Levy, and V. Giguere
Estrogen-related Receptor {alpha} (ERR{alpha}) Is a Transcriptional Regulator of Apolipoprotein A-IV and Controls Lipid Handling in the Intestine
J. Biol. Chem., December 10, 2004; 279(50): 52052 - 52058.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. M. Huss, I. P. Torra, B. Staels, V. Giguere, and D. P. Kelly
Estrogen-Related Receptor {alpha} Directs Peroxisome Proliferator-Activated Receptor {alpha} Signaling in the Transcriptional Control of Energy Metabolism in Cardiac and Skeletal Muscle
Mol. Cell. Biol., October 15, 2004; 24(20): 9079 - 9091.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
B Horard, A Castet, P-L Bardet, V Laudet, V Cavailles, and J-M Vanacker
Dimerization is required for transactivation by estrogen-receptor-related (ERR) orphan receptors: evidence from amphioxus ERR
J. Mol. Endocrinol., October 1, 2004; 33(2): 493 - 509.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. M. Huss and D. P. Kelly
Nuclear Receptor Signaling and Cardiac Energetics
Circ. Res., September 17, 2004; 95(6): 568 - 578.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. J. Willy, I. R. Murray, J. Qian, B. B. Busch, W. C. Stevens Jr., R. Martin, R. Mohan, S. Zhou, P. Ordentlich, P. Wei, et al.
Regulation of PPAR{gamma} coactivator 1{alpha} (PGC-1{alpha}) signaling by an estrogen-related receptor {alpha} (ERR{alpha}) ligand
PNAS, June 15, 2004; 101(24): 8912 - 8917.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Laganiere, G. B. Tremblay, C. R. Dufour, S. Giroux, F. Rousseau, and V. Giguere
A Polymorphic Autoregulatory Hormone Response Element in the Human Estrogen-related Receptor {alpha} (ERR{alpha}) Promoter Dictates Peroxisome Proliferator-activated Receptor {gamma} Coactivator-1{alpha} Control of ERR{alpha} Expression
J. Biol. Chem., April 30, 2004; 279(18): 18504 - 18510.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. N. Schreiber, R. Emter, M. B. Hock, D. Knutti, J. Cardenas, M. Podvinec, E. J. Oakeley, and A. Kralli
The estrogen-related receptor {alpha} (ERR{alpha}) functions in PPAR{gamma} coactivator 1{alpha} (PGC-1{alpha})-induced mitochondrial biogenesis
PNAS, April 27, 2004; 101(17): 6472 - 6477.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
D. P. Kelly and R. C. Scarpulla
Transcriptional regulatory circuits controlling mitochondrial biogenesis and function
Genes & Dev., February 15, 2004; 18(4): 357 - 368.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. CANNON and J. NEDERGAARD
Brown Adipose Tissue: Function and Physiological Significance
Physiol Rev, January 1, 2004; 84(1): 277 - 359.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Luo, R. Sladek, J. Carrier, J.-A. Bader, D. Richard, and V. Giguere
Reduced Fat Mass in Mice Lacking Orphan Nuclear Receptor Estrogen-Related Receptor {alpha}
Mol. Cell. Biol., November 15, 2003; 23(22): 7947 - 7956.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Liu, Z. Zhang, W. Gladwell, and C. T. Teng
Estrogen Stimulates Estrogen-Related Receptor {alpha} Gene Expression through Conserved Hormone Response Elements
Endocrinology, November 1, 2003; 144(11): 4894 - 4904.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Kamei, H. Ohizumi, Y. Fujitani, T. Nemoto, T. Tanaka, N. Takahashi, T. Kawada, M. Miyoshi, O. Ezaki, and A. Kakizuka
PPAR{gamma} coactivator 1{beta}/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity
PNAS, October 14, 2003; 100(21): 12378 - 12383.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Rhee, Y. Inoue, J. C. Yoon, P. Puigserver, M. Fan, F. J. Gonzalez, and B. M. Spiegelman
Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): Requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis
PNAS, April 1, 2003; 100(7): 4012 - 4017.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. N. Schreiber, D. Knutti, K. Brogli, T. Uhlmann, and A. Kralli
The Transcriptional Coactivator PGC-1 Regulates the Expression and Activity of the Orphan Nuclear Receptor Estrogen-Related Receptor alpha (ERRalpha )
J. Biol. Chem., March 7, 2003; 278(11): 9013 - 9018.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ichida, S. Nemoto, and T. Finkel
Identification of a Specific Molecular Repressor of the Peroxisome Proliferator-activated Receptor gamma Coactivator-1 alpha (PGC-1alpha )
J. Biol. Chem., December 20, 2002; 277(52): 50991 - 50995.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Huss, R. P. Kopp, and D. P. Kelly
Peroxisome Proliferator-activated Receptor Coactivator-1alpha (PGC-1alpha ) Coactivates the Cardiac-enriched Nuclear Receptors Estrogen-related Receptor-alpha and -gamma . IDENTIFICATION OF NOVEL LEUCINE-RICH INTERACTION MOTIF WITHIN PGC-1alpha
J. Biol. Chem., October 18, 2002; 277(43): 40265 - 40274.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Bonnelye, V. Kung, C. Laplace, D. L. Galson, and J. E. Aubin
Estrogen Receptor-Related Receptor {alpha} Impinges on the Estrogen Axis in Bone: Potential Function in Osteoporosis
Endocrinology, September 1, 2002; 143(9): 3658 - 3670.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Kraus, E. A. Ariazi, M. L. Farrell, and J. E. Mertz
Estrogen-related Receptor alpha 1 Actively Antagonizes Estrogen Receptor-regulated Transcription in MCF-7 Mammary Cells
J. Biol. Chem., June 28, 2002; 277(27): 24826 - 24834.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J.-A. Gustafsson
Mechanisms of Estrogen Action
Physiol Rev, October 1, 2001; 81(4): 1535 - 1565.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Lu, Y. Kiriyama, K. Y. Lee, and V. Giguere
Transcriptional Regulation of the Estrogen-inducible pS2 Breast Cancer Marker Gene by the ERR Family of Orphan Nuclear Receptors
Cancer Res., September 1, 2001; 61(18): 6755 - 6761.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Coward, D. Lee, M. V. Hull, and J. M. Lehmann
4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma
PNAS, July 5, 2001; (2001) 151244398.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
E. Bonnelye, L. Merdad, V. Kung, and J.E. Aubin
The Orphan Nuclear Estrogen Receptor-related Receptor {alpha} (ERR{alpha}) Is Expressed throughout Osteoblast Differentiation and Regulates Bone Formation In Vitro
J. Cell Biol., May 21, 2001; 153(5): 971 - 984.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Penfornis, S. Viengchareun, D. Le Menuet, F. Cluzeaud, M.-C. Zennaro, and M. Lombes
The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes
Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E386 - E394.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. Giguère
Orphan Nuclear Receptors: From Gene to Function
Endocr. Rev., October 1, 1999; 20(5): 689 - 725.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Cresci, M. L. Clabby, and D. P. Kelly
Evidence for a Novel Cardiac-enriched Retinoid X Receptor Partner
J. Biol. Chem., September 3, 1999; 274(36): 25668 - 25674.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Zhang and C. T. Teng
Estrogen Receptor-related Receptor alpha 1 Interacts with Coactivator and Constitutively Activates the Estrogen Response Elements of the Human Lactoferrin Gene
J. Biol. Chem., June 30, 2000; 275(27): 20837 - 20846.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Coward, D. Lee, M. V. Hull, and J. M. Lehmann
4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma
PNAS, July 17, 2001; 98(15): 8880 - 8884.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vega, R. B.
Right arrow Articles by Kelly, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vega, R. B.
Right arrow Articles by Kelly, D. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement